Skip to main content

Advertisement

ADVERTISEMENT

News

News
12/14/2018
In a Keynote session at the 2018 AIBD Meeting, Dr James Lindsay highlighted the use of biologics and biosimilars, as well as its challenges, for the treatment of ulcerative colitis and Crohn disease.
In a Keynote session at the 2018 AIBD Meeting, Dr James Lindsay highlighted the use of biologics and biosimilars, as well as its challenges, for the treatment of ulcerative colitis and Crohn disease.
In a Keynote session at the 2018...
12/14/2018
Advances in Inflammatory Bowel Disease Network

Advertisement

News
12/14/2018
Researchers analyzed whether health care providers are meeting the clinical needs of patients with Crohn disease during pregnancy.
Researchers analyzed whether health care providers are meeting the clinical needs of patients with Crohn disease during pregnancy.
Researchers analyzed whether...
12/14/2018
Advances in Inflammatory Bowel Disease Network
News
12/13/2018
At the 2018 AIBD Meeting, Dr William Sandborn discusses the biologics and positioning of anti-interleukin-12 and anti-interleukin-23 agents for inflammatory bowel disease.
At the 2018 AIBD Meeting, Dr William Sandborn discusses the biologics and positioning of anti-interleukin-12 and anti-interleukin-23 agents for inflammatory bowel disease.
At the 2018 AIBD Meeting, Dr...
12/13/2018
Advances in Inflammatory Bowel Disease Network
News
12/13/2018
At the 2018 AIBD Meeting, Dr Bruce Sands discusses the use of tofacitinib for ulcerative colitis and other novel JAK inhibitors for Crohn disease.
At the 2018 AIBD Meeting, Dr Bruce Sands discusses the use of tofacitinib for ulcerative colitis and other novel JAK inhibitors for Crohn disease.
At the 2018 AIBD Meeting, Dr...
12/13/2018
Advances in Inflammatory Bowel Disease Network

Advertisement

News
12/13/2018
In a Keynote session at the 2018 AIBD Meeting, Dr Eugene Chang discusses the importance of understanding the gut microbiome, genetic pathways in microbes, and its impact on IBD.
In a Keynote session at the 2018 AIBD Meeting, Dr Eugene Chang discusses the importance of understanding the gut microbiome, genetic pathways in microbes, and its impact on IBD.
In a Keynote session at the 2018...
12/13/2018
Advances in Inflammatory Bowel Disease Network
News
12/11/2018
Dr Shilajit Kundu and colleagues evaluated data on more than 10,000 men to determine how prostate cancer affects men with and without inflammatory bowel disease.
Dr Shilajit Kundu and colleagues evaluated data on more than 10,000 men to determine how prostate cancer affects men with and without inflammatory bowel disease.
Dr Shilajit Kundu and colleagues...
12/11/2018
Advances in Inflammatory Bowel Disease Network
News
10/30/2018
Think you know the extraintestinal manifestations among patients with inflammatory bowel disease? Take our quiz to find out if you do!
Think you know the extraintestinal manifestations among patients with inflammatory bowel disease? Take our quiz to find out if you do!
Think you know the...
10/30/2018
Advances in Inflammatory Bowel Disease Network

Advertisement

News
10/17/2018
Researchers performed small RNA sequencing of colon tissue from more than 100 individuals to better understand cellular mechanisms that create heterogeneity in CD.
Researchers performed small RNA sequencing of colon tissue from more than 100 individuals to better understand cellular mechanisms that create heterogeneity in CD.
Researchers performed small RNA...
10/17/2018
Advances in Inflammatory Bowel Disease Network
News
10/11/2018
In a plenary session at ACG 2018, Dr Adeeti Chiplunker from Washington University discussed her research on the effect of magnetic resonance enterography on the management of small bowel Crohn disease.
In a plenary session at ACG 2018, Dr Adeeti Chiplunker from Washington University discussed her research on the effect of magnetic resonance enterography on the management of small bowel Crohn disease.
In a plenary session at ACG...
10/11/2018
Advances in Inflammatory Bowel Disease Network
News
10/08/2018
Researchers at Vanderbilt University Medical Center conducted a retrospective study among more than 400 patients with inflammatory bowel disease to evaluate adherence to injectable biologic therapy.
Researchers at Vanderbilt University Medical Center conducted a retrospective study among more than 400 patients with inflammatory bowel disease to evaluate adherence to injectable biologic therapy.
Researchers at Vanderbilt...
10/08/2018
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement